Full Year 2011 GAAP EPS Decreased 16 Percent to $4.04 Due to a One-Time Charge
2012 Total Revenue and Adjusted EPS Expected to be in the Range of $16.1-$16.5 Billion and $5.90-$6.15, Respectively
Amgen reported total revenue increased 3 percent during the fourth quarter of 2011 to $3,973 million versus $3,841 million in the fourth quarter of 2010. For the full year 2011, total revenue increased 4 percent to $15,582 million from $15,053 million in 2010.
Read the rest of this entrySOURCE